Cargando…
Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis
BACKGROUND: Although immediate potentially allergic reactions have been reported after dose 1 of mRNA coronavirus disease 2019 (COVID-19) vaccines, comprehensively defined subtypes have not been clearly distinguished. OBJECTIVE: To define distinct clinical phenotypes of immediate reactions after dos...
Autores principales: | Stone, Cosby A., Robinson, Lacey B., Li, Lily, Krantz, Matthew S., Kwah, Jason H., Ortega, Gilbert, Mancini, Christian, Wolfson, Anna R., Saff, Rebecca R., Samarakoon, Upeka, Hong, David I., Koo, Grace, Chow, Timothy G., Gruchalla, Rebecca, Liao, Jane X., Kuster, John K., Price, Christina, Ahola, Catherine, Khan, David A., Phillips, Elizabeth J., Banerji, Aleena, Blumenthal, Kimberly G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468049/ https://www.ncbi.nlm.nih.gov/pubmed/36108922 http://dx.doi.org/10.1016/j.jaip.2022.08.048 |
Ejemplares similares
-
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing
por: Wolfson, Anna R., et al.
Publicado: (2021) -
Urticaria after COVID-19 vaccination and vaccine hesitancy
por: Judd, Allen, et al.
Publicado: (2023) -
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach
por: Banerji, Aleena, et al.
Publicado: (2021) -
Reply to “PEG skin testing for COVID-19 allergy”
por: Banerji, Aleena, et al.
Publicado: (2021) -
COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach
por: Banerji, Aleena, et al.
Publicado: (2021)